WHO ICTRP trial
Treatment with N-acetylcysteine for skin picking in children and young adults…
EUCTR2019-000735-61-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-000735-61-NL |
|---|---|
| Public title | Treatment with N-acetylcysteine for skin picking in children and young adults with PWS |
| Scientific title | N- acetylcysteine treatment for skin picking in children and young adults with PWS: a randomized, controlled, cross-over trial. |
| Primary sponsor | Dutch Growth Research Foundation |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Prader-Willi syndrome MedDRA version: 20.0 Level: PT Classification code 10036476 Term: Prader-Willi syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Hormonal diseases… |
| Interventions | Trade Name: Fluimucil (acetylcysteine) Product Name: Fluimucil Product Code: R05CB01 Pharmaceutical Form: Effervescent tablet |
| Registration date | Apr 8, 2020 |
| Target size | 35 |
| Secondary IDs | SP-NAC19 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: